Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1975 entries
Sorted by: Best Match Show Resources per page
Serpentine supravenous hyperpigmentation.

Clinical case reports

Jamalpur I, Mogili HR, Koratala A.
PMID: 28878924
Clin Case Rep. 2017 Jul 25;5(9):1546-1547. doi: 10.1002/ccr3.1102. eCollection 2017 Sep.

Serpentine supravenous hyperpigmentation is a peculiar cutaneous eruption that follows the path of vein after intravenous injection of the chemotherapeutic agent. The lesions gradually resolve spontaneously if administration of the offending agent is stopped through the affected limb. Drugs...

Cite
Jamalpur I, Mogili HR, Koratala A. Serpentine supravenous hyperpigmentation. Clin Case Rep. 2017;5(9):1546-1547doi: 10.1002/ccr3.1102.
Jamalpur, I., Mogili, H. R., & Koratala, A. (2017). Serpentine supravenous hyperpigmentation. Clinical case reports, 5(9), 1546-1547. https://doi.org/10.1002/ccr3.1102
Jamalpur, Indirakshi, et al. "Serpentine supravenous hyperpigmentation." Clinical case reports vol. 5,9 (2017): 1546-1547. doi: https://doi.org/10.1002/ccr3.1102
Jamalpur I, Mogili HR, Koratala A. Serpentine supravenous hyperpigmentation. Clin Case Rep. 2017 Jul 25;5(9):1546-1547. doi: 10.1002/ccr3.1102. eCollection 2017 Sep. PMID: 28878924; PMCID: PMC5582224.
Copy Download .nbib Format: NLM
Recurrent Kikuchi's Disease Treated by Hydroxychloroquine.

Infection & chemotherapy

Hyun M, So IT, Kim HA, Jung H, Ryu SY.
PMID: 27433383
Infect Chemother. 2016 Jun;48(2):127-31. doi: 10.3947/ic.2016.48.2.127. Epub 2016 Jun 30.

Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting disease, with a specific histopathology. It can be diagnosed clinically, and specific symptoms include fever and cervical lymphadenopathy. The histological finding of KFD in cervical lymph nodes includes necrotizing lymphadenitis. KFD needs...

Cite
Hyun M, So IT, Kim HA, et al. Recurrent Kikuchi's Disease Treated by Hydroxychloroquine. Infect Chemother. 2016;48(2):127-31doi: 10.3947/ic.2016.48.2.127.
Hyun, M., So, I. T., Kim, H. A., Jung, H., & Ryu, S. Y. (2016). Recurrent Kikuchi's Disease Treated by Hydroxychloroquine. Infection & chemotherapy, 48(2), 127-31. https://doi.org/10.3947/ic.2016.48.2.127
Hyun, Miri, et al. "Recurrent Kikuchi's Disease Treated by Hydroxychloroquine." Infection & chemotherapy vol. 48,2 (2016): 127-31. doi: https://doi.org/10.3947/ic.2016.48.2.127
Hyun M, So IT, Kim HA, Jung H, Ryu SY. Recurrent Kikuchi's Disease Treated by Hydroxychloroquine. Infect Chemother. 2016 Jun;48(2):127-31. doi: 10.3947/ic.2016.48.2.127. Epub 2016 Jun 30. PMID: 27433383; PMCID: PMC4945722.
Copy Download .nbib Format: NLM
Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine.

Skin appendage disorders

Contin LA, Martins da Costa Marques ER, Noriega L.
PMID: 28232926
Skin Appendage Disord. 2017 Jan;2(3):162-165. doi: 10.1159/000452925. Epub 2016 Nov 12.

Lupus erythematosus, especially the discoid form, and lichen planopilaris may be associated and can occur in different topographies (coexistence) or in the same lesion (lupus eythematosus/lichen planus overlap syndrome). Frontal fibrosing alopecia is considered a variant form of lichen...

Cite
Contin LA, Martins da Costa Marques ER, Noriega L. Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine. Skin Appendage Disord. 2016;2(3):162-165doi: 10.1159/000452925.
Contin, L. A., Martins da Costa Marques, E. R., & Noriega, L. (2017). Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine. Skin appendage disorders, 2(3), 162-165. https://doi.org/10.1159/000452925
Contin, Letícia Arsie, et al. "Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine." Skin appendage disorders vol. 2,3 (2017): 162-165. doi: https://doi.org/10.1159/000452925
Contin LA, Martins da Costa Marques ER, Noriega L. Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine. Skin Appendage Disord. 2017 Jan;2(3):162-165. doi: 10.1159/000452925. Epub 2016 Nov 12. PMID: 28232926; PMCID: PMC5264358.
Copy Download .nbib Format: NLM
Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study.

Medical hypothesis, discovery & innovation ophthalmology journal

Espandar G, Moghimi J, Ghorbani R, Pourazizi M, Seiri MA, Khosravi S.
PMID: 28293646
Med Hypothesis Discov Innov Ophthalmol. 2016;5(2):41-46.

Hydroxychloroquine (HCQ) is an antimalarial medication that can also be used to treat autoimmune diseases. However, it can produce irreversible changes to the retina that lead to visual impairment. The aim of this study was to determine the proportion...

Cite
Espandar G, Moghimi J, Ghorbani R, et al. Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study. Med Hypothesis Discov Innov Ophthalmol. 2016;5(2):41-46
Espandar, G., Moghimi, J., Ghorbani, R., Pourazizi, M., Seiri, M. A., & Khosravi, S. (2016). Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study. Medical hypothesis, discovery & innovation ophthalmology journal, 5(2), 41-46.
Espandar, Goldis, et al. "Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study." Medical hypothesis, discovery & innovation ophthalmology journal vol. 5,2 (2016): 41-46.
Espandar G, Moghimi J, Ghorbani R, Pourazizi M, Seiri MA, Khosravi S. Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study. Med Hypothesis Discov Innov Ophthalmol. 2016;5(2):41-46. PMID: 28293646; PMCID: PMC5347188.
Copy Download .nbib Format: NLM
THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society

Becerril J, Gonzales H, Saketkoo LA.
PMID: 27159479
J La State Med Soc. 2015 May-Jun;167(3):154-5. Epub 2015 Jun 15.

An 80-year-old man presented with a complaint of three months of fatigue and aching of his shoulders and hips, as well as pain, swelling, and stiffness in bilateral fingers that was worse in the morning but improved with movement....

Cite
Becerril J, Gonzales H, Saketkoo LA. THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY. J La State Med Soc. 2015;167(3):154-5
Becerril, J., Gonzales, H., & Saketkoo, L. A. (2015). THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 167(3), 154-5.
Becerril, J, et al. "THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY." The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society vol. 167,3 (2015): 154-5.
Becerril J, Gonzales H, Saketkoo LA. THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY. J La State Med Soc. 2015 May-Jun;167(3):154-5. Epub 2015 Jun 15. PMID: 27159479.
Copy Download .nbib Format: NLM
Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients.

JAAD case reports

Nissen CV, Wulf HC.
PMID: 27051848
JAAD Case Rep. 2016 Mar 04;2(2):117-8. doi: 10.1016/j.jdcr.2016.01.005. eCollection 2016 Mar.

No abstract available.

Cite
Nissen CV, Wulf HC. Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients. JAAD Case Rep. 2016;2(2):117-8doi: 10.1016/j.jdcr.2016.01.005.
Nissen, C. V., & Wulf, H. C. (2016). Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients. JAAD case reports, 2(2), 117-8. https://doi.org/10.1016/j.jdcr.2016.01.005
Nissen, Christoffer V, and Wulf, Hans Christian. "Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients." JAAD case reports vol. 2,2 (2016): 117-8. doi: https://doi.org/10.1016/j.jdcr.2016.01.005
Nissen CV, Wulf HC. Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patients. JAAD Case Rep. 2016 Mar 04;2(2):117-8. doi: 10.1016/j.jdcr.2016.01.005. eCollection 2016 Mar. PMID: 27051848; PMCID: PMC4810278.
Copy Download .nbib Format: NLM
Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity.

Taiwan journal of ophthalmology

Chang CY, Sheu SJ.
PMID: 29018757
Taiwan J Ophthalmol. 2017 Jan-Mar;7(1):56-58. doi: 10.4103/tjo.tjo_26_17.

The aim of this study is to report a rare case of macular edema as a presentation of hydroxychloroquine-related retinal toxicity. We presented a case of a 46-year-old female patient using hydroxychloroquine for underlying rheumatoid arthritis (RA) with blurred...

Cite
Chang CY, Sheu SJ. Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity. Taiwan J Ophthalmol. 2017;7(1):56-58doi: 10.4103/tjo.tjo_26_17.
Chang, C. Y., & Sheu, S. J. (2017). Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity. Taiwan journal of ophthalmology, 7(1), 56-58. https://doi.org/10.4103/tjo.tjo_26_17
Chang, Chih-Yao, and Sheu, Shwu-Jiuan. "Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity." Taiwan journal of ophthalmology vol. 7,1 (2017): 56-58. doi: https://doi.org/10.4103/tjo.tjo_26_17
Chang CY, Sheu SJ. Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity. Taiwan J Ophthalmol. 2017 Jan-Mar;7(1):56-58. doi: 10.4103/tjo.tjo_26_17. PMID: 29018757; PMCID: PMC5525604.
Copy Download .nbib Format: NLM
Pericentral hydroxychloroquine retinopathy in a Caucasian female.

American journal of ophthalmology case reports

Anand N, Prinzi RA, Hoeferlin C, Yan J, Jain N.
PMID: 29577098
Am J Ophthalmol Case Rep. 2018 Jan 13;9:93-95. doi: 10.1016/j.ajoc.2018.01.019. eCollection 2018 Mar.

PURPOSE: To report a rare presentation of the pericentral pattern of hydroxychloroquine (HCQ) retinal toxicity in a Caucasian female.OBSERVATIONS: The patient presented with 20 years of exposure to HCQ, at a daily dose of 5.2mg/kg of actual body weight,...

Cite
Anand N, Prinzi RA, Hoeferlin C, et al. Pericentral hydroxychloroquine retinopathy in a Caucasian female. Am J Ophthalmol Case Rep. 2018;9:93-95doi: 10.1016/j.ajoc.2018.01.019.
Anand, N., Prinzi, R. A., Hoeferlin, C., Yan, J., & Jain, N. (2018). Pericentral hydroxychloroquine retinopathy in a Caucasian female. American journal of ophthalmology case reports, 993-95. https://doi.org/10.1016/j.ajoc.2018.01.019
Anand, Nikhil, et al. "Pericentral hydroxychloroquine retinopathy in a Caucasian female." American journal of ophthalmology case reports vol. 9 (2018): 93-95. doi: https://doi.org/10.1016/j.ajoc.2018.01.019
Anand N, Prinzi RA, Hoeferlin C, Yan J, Jain N. Pericentral hydroxychloroquine retinopathy in a Caucasian female. Am J Ophthalmol Case Rep. 2018 Jan 13;9:93-95. doi: 10.1016/j.ajoc.2018.01.019. eCollection 2018 Mar. PMID: 29577098; PMCID: PMC5861633.
Copy Download .nbib Format: NLM
A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery.

International journal of surgery case reports

Demir D, Öcal F, Abanoz M, Dermenci H.
PMID: 25460494
Int J Surg Case Rep. 2014;5(12):1282-4. doi: 10.1016/j.ijscr.2014.11.052. Epub 2014 Nov 20.

INTRODUCTION: Thrombocytopenia is a common problem occurring in patients and drug-induced thrombocytopenia is a significant cause of thrombocytopenia.PRESENTATION OF CASE: We present an unusual case of thrombocytopenia that was considered to be associated with the use of hydroxychloroquine in...

Cite
Demir D, Öcal F, Abanoz M, et al. A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery. Int J Surg Case Rep. 2014;5(12):1282-4doi: 10.1016/j.ijscr.2014.11.052.
Demir, D., Öcal, F., Abanoz, M., & Dermenci, H. (2014). A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery. International journal of surgery case reports, 5(12), 1282-4. https://doi.org/10.1016/j.ijscr.2014.11.052
Demir, Deniz, et al. "A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery." International journal of surgery case reports vol. 5,12 (2014): 1282-4. doi: https://doi.org/10.1016/j.ijscr.2014.11.052
Demir D, Öcal F, Abanoz M, Dermenci H. A case of thrombocytopenia associated with the use of hydroxychloroquine following open heart surgery. Int J Surg Case Rep. 2014;5(12):1282-4. doi: 10.1016/j.ijscr.2014.11.052. Epub 2014 Nov 20. PMID: 25460494; PMCID: PMC4276277.
Copy Download .nbib Format: NLM
Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases.

Experimental and therapeutic medicine

Li M, Gao W, Ma J, Zhu Y, Li X.
PMID: 26622376
Exp Ther Med. 2015 Aug;10(2):689-692. doi: 10.3892/etm.2015.2510. Epub 2015 May 21.

The oxidative-antioxidative status is closely associated with the progression of systemic lupus erythematosus (SLE), and oxidative stress is customarily found in patients with SLE. N-acetylcysteine (NAC), a typical antioxidant, is reliable and often applied for clinical treatment. Lupus nephritis...

Cite
Li M, Gao W, Ma J, et al. Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases. Exp Ther Med. 2015;10(2):689-692doi: 10.3892/etm.2015.2510.
Li, M., Gao, W., Ma, J., Zhu, Y., & Li, X. (2015). Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases. Experimental and therapeutic medicine, 10(2), 689-692. https://doi.org/10.3892/etm.2015.2510
Li, Ming, et al. "Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases." Experimental and therapeutic medicine vol. 10,2 (2015): 689-692. doi: https://doi.org/10.3892/etm.2015.2510
Li M, Gao W, Ma J, Zhu Y, Li X. Early-stage lupus nephritis treated with N-acetylcysteine: A report of two cases. Exp Ther Med. 2015 Aug;10(2):689-692. doi: 10.3892/etm.2015.2510. Epub 2015 May 21. PMID: 26622376; PMCID: PMC4509375.
Copy Download .nbib Format: NLM
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response.

Hepatic medicine : evidence and research

Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T.
PMID: 26955295
Hepat Med. 2016 Feb 22;8:9-20. doi: 10.2147/HMER.S63700. eCollection 2016.

Autophagy is an intracellular lysosomal degradation process performed by the cells to maintain energy balance. The autophagy response plays an important role in the progression of liver disease due to hepatitis virus infection, alcoholic liver disease, nonalcoholic fatty liver...

Cite
Dash S, Chava S, Chandra PK, et al. Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepat Med. 2016;8:9-20doi: 10.2147/HMER.S63700.
Dash, S., Chava, S., Chandra, P. K., Aydin, Y., Balart, L. A., & Wu, T. (2016). Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepatic medicine : evidence and research, 89-20. https://doi.org/10.2147/HMER.S63700
Dash, Srikanta, et al. "Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response." Hepatic medicine : evidence and research vol. 8 (2016): 9-20. doi: https://doi.org/10.2147/HMER.S63700
Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T. Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepat Med. 2016 Feb 22;8:9-20. doi: 10.2147/HMER.S63700. eCollection 2016. PMID: 26955295; PMCID: PMC4772942.
Copy Download .nbib Format: NLM
Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients.

Therapeutics and clinical risk management

Chen HH, Chen DY, Lin CC, Chen YM, Lai KL, Lin CH.
PMID: 28496328
Ther Clin Risk Manag. 2017 May 02;13:583-592. doi: 10.2147/TCRM.S130666. eCollection 2017.

PURPOSE: The aim of this study is to investigate the association between the use of disease-modifying antirheumatic drugs (DMARDs) and diabetes mellitus (DM) in patients with ankylosing spondylitis (AS), rheumatoid arthritis (RA), or psoriasis/psoriatic arthritis (PS/PSA).PATIENTS AND METHODS: This...

Cite
Chen HH, Chen DY, Lin CC, et al. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. Ther Clin Risk Manag. 2017;13:583-592doi: 10.2147/TCRM.S130666.
Chen, H. H., Chen, D. Y., Lin, C. C., Chen, Y. M., Lai, K. L., & Lin, C. H. (2017). Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. Therapeutics and clinical risk management, 13583-592. https://doi.org/10.2147/TCRM.S130666
Chen, Hsin-Hua, et al. "Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients." Therapeutics and clinical risk management vol. 13 (2017): 583-592. doi: https://doi.org/10.2147/TCRM.S130666
Chen HH, Chen DY, Lin CC, Chen YM, Lai KL, Lin CH. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. Ther Clin Risk Manag. 2017 May 02;13:583-592. doi: 10.2147/TCRM.S130666. eCollection 2017. PMID: 28496328; PMCID: PMC5422572.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1975 entries